What are the key financial statements provided in this 10-Q filing?

This filing includes Condensed Consolidated Balance Sheets as of July 2, 2000 and December 31, 1999, Condensed Consolidated Statements of Income for the three and six months ended July 2, 2000 and July 4, 1999, and Condensed Consolidated Statements of Cash Flows for the six months ended July 2, 2000 and July 4, 1999.

Where can I find more detailed information about the company's performance and financial position?

Investors should refer to Item 2, 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' which offers management's perspective on the company's performance, financial condition, and future prospects.

What is the total number of Teradyne's outstanding common shares as of the reporting period?

As of July 28, 2000, the number of shares outstanding of Teradyne's only class of Common Stock was 173,441,376 shares.

Does Teradyne have any significant legal proceedings to report?

Item 1 of Part II, 'Legal Proceedings,' would contain information on any significant legal matters. As this is a table of contents, investors would need to consult the full text of the filing for specifics regarding legal proceedings.

TER 10-Q Quarterly Report Q3 FY2000 — Revenue, Net Income, EPS

Summary

Teradyne, Inc. (TER) reported its quarterly results for the period ending July 2, 2000. The filing provides a snapshot of the company's financial health, including its balance sheet, income statement, and cash flow statement for the relevant periods. Investors should pay close attention to the 'Management's Discussion and Analysis of Financial Condition and Results of Operations' section for detailed insights into the company's performance drivers, challenges, and outlook. Key metrics such as revenue, profitability, and cash generation are critical for assessing the company's trajectory.

Key Highlights

1The report covers the quarterly period ended July 2, 2000.
2Key financial statements included are Condensed Consolidated Balance Sheets, Statements of Income, and Statements of Cash Flows.
3The filing indicates Teradyne has met its reporting requirements for the preceding 12 months and the last 90 days.
4As of July 28, 2000, Teradyne had 173,441,376 shares of Common Stock outstanding.
5Detailed notes to the consolidated financial statements are provided for further clarification.
6Management's Discussion and Analysis (MD&A) is a crucial section for understanding operational performance and financial condition.

TERADYNE, INC Quarterly Report for Q3 Ended Jul 2, 2000

Summary

Key Highlights

Frequently Asked Questions